Skip to content

Exelixis EXEL Cash ratio

Cash ratio at other companies

Eli Lilly logo
Eli LillyLLY
0.1×0.0×
Pfizer logo
PfizerPFE
0.1×0.0×
Summit Therapeutics logo
Summit TherapeuticsSMMT
0.1×-0.1×
Incyte logo
IncyteINCY
2.3×+1.2×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.2×-0.8×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.1×-2.5×

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Calculated from Exelixis’s reported figures.

Based on the most recent quarter.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's cash ratio?
Exelixis (EXEL) reported cash ratio of 0.6× in Q1 2026.
How has Exelixis's cash ratio changed year-over-year?
Exelixis's cash ratio increased by 32.4% year-over-year, from 0.5× to 0.6×.
What is the long-term trend for Exelixis's cash ratio?
Over 5 years (2020 to 2025), Exelixis's cash ratio has grown at a -5.4% compound annual growth rate (CAGR), from 1.6× to 1.2×.
What does cash ratio mean?
How much of its short-term bills the company could pay with cash on hand right now.
How do you interpret cash ratio?
A buffer against stress, but persistently high cash ratios can indicate under-deployed capital. Interpret alongside the company's capital-allocation strategy.
How does cash ratio compare across companies?
Varies widely by business model and treasury policy; best read against the company's own history.